Why Life Science Companies May Explore Relocation to Zurich
As an anchor sponsor for OneMedForum NY 2012, The Greater Zurich Area AG will be hosting a workshop Thursday morning on “Entering Europe.”
News
NYSE to Host OneMedForum Finance Reception 2011 July 11th
The networking reception at this historic venue will feature a special keynote in the board room of the Stock Exchange from David Weild IV, former NASDAQ Vice Chair.
SIX Swiss Exchange Offers More Visibility and Detail
Marco Estermann, Head Issuer Relations of SIX Swiss Exchange in the Greater Zurich Area sat down with OneMedRadio to discuss the growth of the Swiss biotech sector and particularly different strategies this sector employs to raise capital.
Twitter’s Top 10 Healthcare Journalists To Follow
Below, we list the top ten healthcare journalists on Twitter improving the quality, accuracy and visibility of health care reporting and writing.
Jason Napodano Discusses the “Buzz Word” Regenerative Medicine and Why its a Hot Area in Biotech
Napodano, a senior biotech analyst for Zacks Investment Research discusses 4 regenerative medicine companies making headway in the space.
BDO Says That Biotech Has Seen a Significant Increase in Compensation
As a sponsor for the third annual OneMedForum New York to be held July 11-12, BDO Life Sciences will host a special workshop to discuss compensation practices at life sciences companies.
A Decade of War Pushes PTSD To the Forefront in Healthcare Concerns
As the US begins to see more and more soldiers return home from combat after the last decade of wars, finding a viable treatment for PTSD should and will be a more prominent concern in the minds of many.
Agilent Technologies Acquires Cancer Diagnostics Company, Dako In Largest Acquisition To Date
OneMedForum New York 2012 will offer a diagnostics panel session on the afternoon of July 12th to discuss the rapid technological advances in diagnostics and personalized medicine.
InVivo Therapeutics Protects And Regenerates The Spinal Cord Resulting in Functional Improvement Below the Injury
Frank Reynolds, of InVivo Therapeutics (NVIV), says the company is on the verge of unprecedented technology for the treatment of the spinal cord.
Zymeworks Invited to Present AntiBody Technology at OneMedForum NY 2012
Zymeworks Inc. is a privately held biotechnology company committed to developing best-in-class protein therapeutics for the treatment of cancer.